YIELD10 BIOSCIENCE, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Yield10 Bioscience, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Yield10 Bioscience, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$3.2M, a 12.7% increase year-over-year.
  • Yield10 Bioscience, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$12.6M, a 11.1% increase year-over-year.
  • Yield10 Bioscience, Inc. annual Operating Income (Loss) for 2023 was -$14.4M, a 7.18% decline from 2022.
  • Yield10 Bioscience, Inc. annual Operating Income (Loss) for 2022 was -$13.5M, a 15% decline from 2021.
  • Yield10 Bioscience, Inc. annual Operating Income (Loss) for 2021 was -$11.7M, a 21.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$12.6M -$3.2M +$464K +12.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$13.1M -$2.44M +$1.36M +35.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$14.4M -$3.25M -$43K -1.34% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$14.4M -$3.7M -$213K -6.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$14.2M -$3.67M -$231K -6.72% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$13.9M -$3.8M -$479K -14.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$13.5M -$3.2M -$236K -7.95% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$13.2M -$3.49M -$399K -12.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$12.8M -$3.44M -$355K -11.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$12.5M -$3.32M -$769K -30.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$11.7M -$2.97M -$358K -13.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 -$11.3M -$3.09M -$897K -40.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$10.4M -$3.08M -$944K -44.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$9.49M -$2.55M +$116K +4.35% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$9.61M -$2.61M -$195K -8.08% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 -$9.41M -$2.19M -$196K -9.81% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$9.22M -$2.14M -$239K -12.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$8.98M -$2.67M -$383K -16.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$8.6M -$2.42M -$520K -27.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$8.08M -$2M +$678K +25.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$8.75M -$1.9M +$533K +21.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 -$9.29M -$2.29M +$32K +1.38% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$9.32M -$1.9M +$634K +25.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-25
Q3 2018 -$9.95M -$2.68M -$694K -35% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$9.26M -$2.43M +$280K +10.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 -$9.54M -$2.32M -$256K -12.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$9.28M -$2.53M -$936K -58.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-28
Q3 2017 -$8.35M -$1.98M +$622K +23.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$8.97M -$2.71M -$203K -8.09% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$8.77M -$2.06M +$1.48M +41.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$10.2M -$1.59M +$4.32M +73.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-12
Q3 2016 -$14.6M -$2.6M +$502K +16.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$15.1M -$2.51M +$3.62M +59.1% Apr 1, 2016 Jun 30, 2016 10-Q/A 2017-10-06
Q1 2016 -$18.7M -$3.54M +$2.29M +39.2% Jan 1, 2016 Mar 31, 2016 10-Q/A 2017-10-06
Q4 2015 -$21M -$5.92M -$110K -1.89% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-29
Q3 2015 -$20.9M -$3.11M +$3.6M +53.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-18
Q2 2015 -$24.5M -$6.13M +$633K +9.36% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$25.1M -$5.83M +$1.66M +22.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$26.8M -$5.81M +$2.16M +27.1% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-29
Q3 2014 -$28.9M -$6.71M -$210K -3.23% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-29
Q2 2014 -$28.7M -$6.76M +$586K +7.98% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-29
Q1 2014 -$29.3M -$7.49M -$760K -11.3% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-29
Q4 2013 -$28.5M -$7.97M +$1.55M +16.3% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-25
Q3 2013 -$30.1M -$6.5M +$1.25M +16.1% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-25
Q2 2013 -$31.3M -$7.35M +$609K +7.65% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-25
Q1 2013 -$32M -$6.73M -$35.6M -123% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-25
Q4 2012 $3.6M -$9.52M +$97K +1.01% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-28
Q3 2012 $3.51M -$7.74M +$1.84M +19.2% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-28
Q2 2012 $1.67M -$7.96M +$2.05M +20.5% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-28
Q1 2012 -$378K $28.8M +$38.5M Jan 1, 2012 Mar 31, 2012 10-K 2014-03-28
Q4 2011 -$38.9M -$9.62M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-28
Q3 2011 -$9.58M +$442K +4.41% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-28
Q2 2011 -$10M -$428K -4.47% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-28
Q1 2011 -$9.66M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-28
Q3 2010 -$10M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-02
Q2 2010 -$9.58M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.